Use of the continuous glucose monitoring system in the management of hypoglicemia in insulin autoimmune syndrome

Publié en ligne: 11 juil. 2022

Pages: 89 - 92

Reçu: 03 janv. 2022

Accepté: 31 mai 2022

DOI: https://doi.org/10.2478/amma-2022-0011

Mots clés

insulin autoimune syndrome, Hirata’s disease, continuous monitoring system, insulin autoantibodies

© 2022 Andrada Raluca Pop et al., published by Sciendo

This work is licensed under the Creative Commons Attribution 4.0 International License.